Moderna’s COVID-19 Vaccine Meets Safety Criteria and Is Highly Effective: FDA Data

A subject receives a shot in the first-stage clinical trial of a potential COVID-19 vaccine at the Kaiser Permanente Washington Health Research Institute in Seattle, Wash., on March 16, 2020. Ted S. Warren/AP Photo

The Food and Drug Administration (FDA) released an analysis of Moderna’s COVID-19 vaccine on Tuesday, concluding it is highly effective and safe.

The FDA’s analysis (pdf) was issued ahead of a Thursday meeting with a panel of independent medical advisers that will discuss whether scientific evidence supports the view that the vaccine, called mRNA-1273, is effective in preventing COVID-19 in people aged 18 and older, and if the known benefits outweigh potential risks.